113 related articles for article (PubMed ID: 3523242)
1. In search of the subcutaneous-insulin-resistance syndrome.
Schade DS; Duckworth WC
N Engl J Med; 1986 Jul; 315(3):147-53. PubMed ID: 3523242
[TBL] [Abstract][Full Text] [Related]
2. Control of diabetes through a subcutaneous peritoneal access device (SPAD) in patients with resistance to subcutaneously injected insulin.
Dandona P; Fonseca V; Fernando O; Menon RK; Weerakoon J; Kurtz A; Stephen R
Diabetes Res; 1987 May; 5(1):47-9. PubMed ID: 3304785
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
Hildebrandt P
Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the absorption kinetics of subcutaneously administered insulin].
Misawa K
Hokkaido Igaku Zasshi; 1989 Nov; 64(6):792-812. PubMed ID: 2691384
[TBL] [Abstract][Full Text] [Related]
5. Aprotinin induced lipohypertrophy and glomerulonephritis in an insulin dependent diabetic.
Dandona P; Mier A; Boag F; Chappell M; Beckett AG
Diabetes Res; 1985 Jul; 2(4):213-6. PubMed ID: 2417774
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
[TBL] [Abstract][Full Text] [Related]
7. Orthostatic changes in subcutaneous blood flow and insulin absorption.
Hildebrandt P; Birch K; Sestoft L; Nielsen SL
Diabetes Res; 1985 Jul; 2(4):187-90. PubMed ID: 3910326
[TBL] [Abstract][Full Text] [Related]
8. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
de Meijer PH; Lutterman JA
Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
[TBL] [Abstract][Full Text] [Related]
10. Insulin absorption: a major factor in apparent insulin resistance and the control of type 2 diabetes mellitus.
Friedberg SJ; Lam YW; Blum JJ; Gregerman RI
Metabolism; 2006 May; 55(5):614-9. PubMed ID: 16631437
[TBL] [Abstract][Full Text] [Related]
11. Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.
Wredling R; Liu D; Lins PE; Adamson U
Diabete Metab; 1991; 17(5):456-9. PubMed ID: 1752346
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes.
Luzio SD; Beck P; Owens DR
Horm Metab Res; 2003 Jul; 35(7):434-8. PubMed ID: 12931275
[TBL] [Abstract][Full Text] [Related]
13. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
14. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G
Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252
[TBL] [Abstract][Full Text] [Related]
15. Skinfold thickness, local subcutaneous blood flow and insulin absorption in diabetic patients.
Hildebrandt P
Acta Physiol Scand Suppl; 1991; 603():41-5. PubMed ID: 1789128
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M
Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.
Rajamand N; Ungerstedt U; Brismar K
Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945
[TBL] [Abstract][Full Text] [Related]
18. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
19. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
Navascués I; Kerner W; Pfeiffer EF
Life Support Syst; 1985; 3(3):263-7. PubMed ID: 3900596
[TBL] [Abstract][Full Text] [Related]
20. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
